Our stock price drop is a joke! Yes, Gerald's cred
Post# of 30028
If we get a grant to fund the Eltoprazine Phase 2b trial to match the grants funding our ESS trial......that alone should put us well above .10 cents!!
The Eltoprazine and ESS clinical trials starting up very soon are both concrete catalysts that should add value to our stock price.
Without a doubt this is a great time to buy.